Cite

HARVARD Citation

    Wang, D. et al. (n.d.). EMBR-30. A NOVEL PLK1 INHIBITOR ONVANSERTIB EFFECTIVELY SENSITIZES GROUP 3 MEDULLOBLASTOMA TO RADIOTHERAPY. Neuro-oncology. p. i12. [Online]. 
  
Back to record